RxDoctor Payments Data

Tamara Khazbieva

Family · Sequim, WANPI 1477225837

Payments from drug & device makers

$3,559in general payments, 2019–2025

Across 140 payments — averaging $25.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$306
  • Amgen$274
  • Merck$228
  • Takeda Pharmaceuticals U.S.A., Inc.$228
  • Genentech USA, Inc.$202
  • Johnson & Johnson$193
  • plus $2K from 35 others

What the payments were for

  • Food & beverage$2,92082%
  • Education$63918%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,559 in reported general payments places this provider in the 90th percentile of 1,706 family providers in Washington.

See all family providers in Washington

Most prescribed under Part D

DrugClaimsCost to plans & patients
ProcritEpoetin Alfa14$61,540
EliquisApixaban41$41,678
Hydroxyurea23$1,530
Anastrozole34$1,457
Fentanyl16$1,246
Letrozole24$1,018
Prochlorperazine Maleate70$779
Fluconazole13$679
Acyclovir31$638
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen23$551
Dexamethasone20$535
Pantoprazole Sodium18$447
Lidocaine-PrilocaineLidocaine/Prilocaine40$443
Oxycodone Hcl17$423
Ondansetron OdtOndansetron34$340

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonProcrit$193$61,54014 claims
PfizerEliquis$96$41,67841 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,706 family providers in Washington.

Other family in Sequim

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →